Zoloft is a type of medication that doctors call a selective serotonin reuptake inhibitor, or SSRI. They may recommend it for mental health conditions, including certain types of bipolar disorder. There are some side effects to consider before using this drug, however, and some may be cause for concern. Anyone who is uncertain about their… Read More: Medical News Today: How does Zoloft affect bipolar disorder? »
FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD Print this page STAMFORD, Conn.–(BUSINESS WIRE) March 01, 2019 –Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved Adhansia XR (methylphenidate hydrochloride) extended-release capsules CII, a central nervous system (CNS) stimulant, for… Read More: FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the… »
COLORADO SPRINGS — The last thing Morgan Stickney remembers from before her lower leg was amputated is lying on a hospital gurney waiting for the anesthesia to take hold. With a debilitating fear racing through her mind, she asked her surgeon to hold her hand. They talked about swimming until she passed out. “It’s the… Read More: A Swimmer Saved by What She Lost »
According to a study published in Cephalalgia, paroxysmal pressing headache has been identified as a new headache syndrome marked by spontaneous attacks without accompaniments that last only a few minutes with pain located in 1 region of 1 side of the head, which can shift between episodes. The investigators of this prospective study sought to… Read More: Paroxysmal Pressing Headache Examined as a New Headache Syndrome –… »